Skip to main content

Table 3 Comparison of postoperative outcomes and complication rates of included patients operated for malignant colorectal neoplasm. RCS robot-assisted colorectal surgery, LCS laparoscopic colorectal surgery, CRP C-reactive protein

From: Improved perioperative outcomes and reduced inflammatory stress response in malignant robot-assisted colorectal resections: a retrospective cohort study of 298 patients

Postoperative outcomes and complication rates

Level

RCS, n =143

LCS, n = 155

p-value

Length of hospital stay, median (IQR), days

4 (4–5)

5 (4–7)

< 0.001b

Time to first flatus, median (IQR), days

2 (1–2)

1 (1–2)

0.145b

Time to first stool, median (IQR), days

3 (2–3)

2 (1–3)

0.033b

Surgical complication rate (Clavien Dindo), n (%)

I-II

7 (4.9%)

11 (7.1%)

0.519a

III-V

8 (5.6%)

13 (8.4%)

 

Type of surgical complication rate (Clavien Dindo IV), n (%)

Postoperative bleeding

3 (2.1%)

4 (2.6%)

 

Ileus

1 (0.7%)

2 (1.3%)

 

Wound abscess

3 (2.1%)

3 (1.9%)

 

Intraabdominal abscess

0 (0%)

1 (0.6%)

 

Stoma complication rate

1 (0.7%)

5 (3.2%)

 

Anastomotic leakage

0 (0%)

1 (0.6%)

 

Other

7 (4.9%)

8 (5.2%)

 

Medical complication rate (Clavien Dindo), n (%)

I-II

18 (12.5%)

28 (18.1%)

0.340a

III-V

6 (4.2%)

3 (1.9%)

 

Type of medical complication rate (Clavien Dindo I-V), n (%)

Acute myocardial infarction

0 (0%)

1 (0.6%)

 

Pneumonia

3 (2.1%)

8 (5.2%)

 

Cardiac insufficiency

3 (2.1%)

3 (1.9%)

 

Pulmonary embolism

1 (0.7%)

3 (1.9%)

 

Respiratory insufficiency

3 (2.1%)

5 (3.2%)

 

Renal insufficiency

2 (1.4%)

4 (2.6%)

 

Sepsis

1 (0.7%)

0 (0%)

 

Other

11 (7.7%)

7 (4.5%)

 

Mortality, n (%)

3 (2.1%)

1 (0.6%)

0.500c

CRP, median (IQR), mg/L

Day 1

43 (26–61)

50 (31–81)

0.027b

Day 2

70.5 (48–120)

82 (46–127)

0.133b

Day 3

64 (40–105)

82 (46–127)

0.037b

Day 4

43 (26–72.5)

53 (34–93)

0.017b

Day 5

30 (19–66)

44 (26–67)

0.169b

Day 6

24 (14–78)

32 (20–62)

0.470b

Day 7

27 (18–54)

35.5 (21–64)

0.358b

Leukocytes, median (IQR), 109/L

Day 1

11 (9–13)

11 (9–13)

0.781b

Day 2

11 (9–12)

10 (8–12)

0.928b

Day 3

9 (7–11)

10 (8–12)

0.158b

Day 4

8 (6–10)

8 (7–11)

0.016b

Day 5

8 (6–11)

9 (7–10)

0.169b

Day 6

8 (7–10)

8 (6–10)

0.557b

Day 7

8.4 (±2.3)

9.0 (±2.9)

0.409b

  1. aχ2-test
  2. bWilcoxon rank sum test